Search
Session handouts and meetings archive
Handouts ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023 Innovation Academy, Tampa, FL, August 10-13 2023 Annual Meeting, New Orleans, LA, March 17-21 Sessions ... 2025 Innovation
CME & session evaluation archive
Claim CME & submit session evaluations ... Claim CME credit and submit session evaluations for attending previous Academy meetings: ... 2025 Innovation Academy, Chicago, IL, July 10-13 2025 Annual Meeting, Orlando, FL, March 7-11 2024 Innovation Academy, Seattle, WA, August 1-4 2024 Annual Meeting, San Diego, CA, March 8-12 2023
AADA hosts largest Capitol Hill skin cancer check in a decade
On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health Fair with the Congressional Skin Cancer Caucus. This event was our largest to date, hosting 198 Hill staffers and 11 members of Congress, performing 127 skin checks, and providing 75 Reveal camera image results.
Prioritizing patient satisfaction
Answers in Practice ... By Emily Margosian, Assistant Editor, March 1, 2024 DermWorld ... talks to Vinod Nambudiri, MD, MBA, EdM, FAAD, associate professor of dermatology at Harvard Medical School, about strategies for improving patient satisfaction. Vinod Nambudiri, MD, MBA, EdM, FAAD ... DermWorld: Tell us about your practice. Dr.
Academy physician leaders meet with federal legislators
On June 4, AADA physician leaders met with legislators in Washington, D.C., as part of the House Call on the Mall fundraiser hosted by the National Republican Congressional Committee and Rep. John Joyce, MD, FAAD (R-PA). During the event, AADA leaders reiterated the importance of Medicare physician payment reform. ...
AADA hosts 10th annual Capitol Hill Skin Cancer Check and Health Fair
Moving the needle ... By Apoorva Stull, Senior Manager, Advocacy Communications, May 1, 2024 DermWorld ... breaks down the latest highlights of AADA advocacy activities at the federal and state legislative and regulatory level. On May 15, the AADA hosted its 10th annual Capitol Hill Skin Cancer Check and Health
Advocacy Update Feb. 4 2025
IN THIS ISSUE / Feb. 4, 2025 Physician champions introduce Medicare physician payment fix in House Academy joins coalition urging less regulatory burdens in Medicare Advantage and Part D program AADA urges CMS to improve MVP framework Become an AADA Advocacy Key Contact Support dermatology champions in Congress through SkinPAC
Taking the challenge: Social media, adolescents, and the skin
By Albert C. Yan, MD June 12, 2019 Vol. 1, No. 14 Patterned skin injury can raise the specter of non-accidental trauma. However, over the past decade or so, striking examples of patterned skin injury have emerged among adolescents and pre-teens that share certain features: these are self-induced voluntarily; the
Advocacy Update Dec 9, 2025
IN THIS ISSUE / Dec. 9, 2025 AADA endorses annual inflationary update to Medicare payment legislation Upcoming formulary prior authorization changes to Blue Cross Blue Shield’s federal employee coverage Podcast highlights advocacy on dermatopathology payer and regulatory challenges AMA offering $1 million in community health program grants Peter Friedman, MD,
On the front lines in Connecticut
Derm World Weekly - A Publication of the American Academy of Dermatology | Association ... DW Weekly talked to Caroline Nelson, MD, from Yale School of Medicine, about her experiences serving in the internal medicine unit during the COVID-19 pandemic. DW Weekly : I understand that you have been serving
Advocacy Update Feb. 18 2025
IN THIS ISSUE / Feb. 18, 2025 AADA, house of medicine demand reversal of Medicare cut and provide a pay boost AADA highlights need for Medicare physician payment reform at House Committee on Ways and Means hearing Dermatology addresses new CLIA requirements for lab directors Legislators reject pharmacists’ effort to
Advocacy Update Mar. 18, 2025
IN THIS ISSUE / Mar. 18, 2025 AADA outraged that Congress passed government funding without doc fix AADA advocates for dermatologists in CLIA lab director requirements FDA testing confirms minimal benzene in most benzoyl peroxide acne products, some voluntary recalls issued Add your voice and become an AADA Advocacy Key
Glucose monitors: Not as sweet as they seem
By Christen M. Mowad, MD Oct. 9, 2019 Vol. 1, No. 31 ... The next contact allergen of the year has been announced early by the American Contact Dermatitis Society and it is an acrylate, isobornyl acrylate. (1) This chemical is a photopolymerizable monomer that has been used in industrial
Researching therapeutic reformation of the capillary malformation: Arteriovenous Malformation Syndrome
By Warren R. Heymann, MD June 17, 2020 Vol. 2, No. 24 Small cutaneous lesions may have profound systemic implications. Astute dermatologists will recognize these lesions and assess patients accordingly, often to the surprise of referring physicians and patients alike. ... The Capillary Malformation – Arteriovenous Malformation (CM-AVM) syndrome was
Key messages to communicate about Indoor tanning
Key messages ... Using indoor tanning beds can increase your risk of skin cancer, including melanoma, the deadliest form of skin cancer. (1-15) ... Using tanning beds before age 20 can increase your chances of developing melanoma by 47%, and the risk increases with each use. (16) ... Women younger
Your Dermatologist Knows media wins 2024
A key part of Your Dermatologist Knows is pitching stories to media outlets in hopes they’ll run news stories sharing information about the wide breadth of knowledge dermatologists have to their readership. We consider every new story published as a result of our pitches as a win, regardless of whether
Biotin supplementation for hair and nail health: Does it pass the test?
By Warren R. Heymann, MD, FAAD November 17, 2021 Vol. 3, No. 46 When patients ask me about biotin supplementation for their hair or nails, the usual question is what dose they should take, not whether or not it has any value. High dose over-the-counter biotin supplements (≥ 5 mg/day,
After 23 years, a syndrome converted me into an eflornithine believer
By Warren R. Heymann, MD, FAAD July 12, 2023 Vol. 5, No. 28 I learned that Vaniqa (eflornithine - ... α -difluoromethylornithine [DFMO]) was discontinued. Topical eflornithine was released in 2000 to reduce facial hirsutism. When the drug was released, I recall being fascinated by the premise of its mechanism.
Links in the care chain
Go to AAD Home ... Go to AAD Home ... Menu ... Dermatologists are key providers in multispecialty care of melanoma, serious skin disease ... Dermatologists are key providers in multispecialty care of melanoma, serious skin disease ... By Jan Bowers, contributing writer A diagnosis of advanced melanoma marks the
Setting the stage
Changes to TNM system enhance prognostication for cutaneous cancers ... Feature ... By Jan Bowers, Contributing Writer, October 1, 2021 When French surgeon Pierre Denoix, MD, pioneered the development of a simple staging system for breast cancer in the 1940s and ’50s, he opened a path for physicians treating many
Promising therapeutic developments for cutaneous lupus erythematosus: Interfering with interferon
By Warren R. Heymann, MD, FAAD Aug. 17, 2022 Vol. 4, No. 33 Disfigurement due to scars and dyspigmentation complicating discoid lupus erythematosus (DLE) can be devastating. The cornerstones of therapy for cutaneous lupus erythematosus (CLE) are steroids (topical, intralesional, systemic) and antimalarials (hydroxychloroquine, chloroquine, quinacrine). Secondary agents include immunosuppressive
Demystifying cancer of the nail
Go to AAD Home ... Go to AAD Home ... Menu ... Unfamiliarity leads to missed diagnoses, reluctance to biopsy ... Unfamiliarity leads to missed diagnoses, reluctance to biopsy ... By Jan Bowers, contributing writer “You can’t trust the nail,” remarked Richard K. Scher, MD, a dermatologist with nearly 50
The nexus of VEXAS syndrome
By Warren R. Heymann, MD, FAAD December 1, 2021 Vol. 3, No. 47 You may not be familiar with VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome, but it is conceivable that you have already unknowingly encountered patients with the disorder. ... To appreciate the clinical nuances of the VEXAS
Exchanging plasma exchange for a novel approach: The potential of FcRn antagonists in dermatologic autoimmune disease
By Warren R. Heymann, MD, FAAD Nov. 1, 2023 Vol. 5, No. 44 Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are potentially life-threatening disorders demanding aggressive therapy with all the finesse and skill that dermatologists can muster. PV is characterized by IgG autoantibodies targeting desmoglein (Dsg)‐3, which is associated with
Our donors
We welcome this year's generous donors into the following giving societies and thank them for their commitment to advancing the programs and services of the Academy, especially those who have given consecutively for the past 5+ years. ... 1938 Legacy Society (Transformational gift) ... Bruce D. Glassman, MD, FAAD ...